GCCC Brings Proton Therapy to South Asia at the 17th Dhaka Medical Exhibition
As the only Chinese medical institution focused on proton therapy at the exhibition, Guangzhou Concord Cancer Center attracted widespread attention from healthcare professionals across Bangladesh and South Asia. Featured in Bangladesh Sun.
Read More →
Photons vs. Protons: How to Choose the Right Radiotherapy for Cancer
A clear, patient-friendly guide: photons are like a searchlight, protons are like a depth charge. Four questions to help you decide with your oncology team.
Read More →
A One-in-a-Million Battle: Indonesian Chordoma Patient's Proton Therapy Journey at GCCC
Rafi, a young Indonesian man with a rare 10cm sacral chordoma, found hope at GCCC after exhausting local options. His story: surgery + proton therapy, and a team that treated him "like family."
Read More →
SpaceOAR Hydrogel + Proton Therapy: Precision Protection for Prostate Cancer Radiotherapy
GCCC pioneers SpaceOAR rectal spacer in China — a 20-minute procedure creating a 1.2cm protective buffer, combined with proton therapy reducing organ radiation by 80%.
Read More →
From Craniotomy to Non-Invasive: Gamma Knife Radiosurgery for Trigeminal Neuralgia
How GCCC's Gamma Knife technology offers 80-90% effective pain relief without open surgery — a breakthrough for patients who have exhausted conventional treatments.
Read More →
"Absolutely Excellent!" — A Bangladeshi Lymphoma Patient's Journey at GCCC
After a 5-year battle with DLBCL, Ms. M traveled 2,000km from Dhaka to Guangzhou. Her verdict on GCCC's multidisciplinary care and international patient services.
Read More →
Proton Therapy Precision Against Dual Primary Cancers: Prostate and Rectosigmoid Cancer
A 60-year-old patient with two primary pelvic cancers achieved pathologic complete response after synchronized proton therapy and concurrent chemotherapy at GCCC.
Read More →
A Beam of Light: One Year of Proton Therapy Operations at GCCC
365 days of clinical proton therapy: 40+ disease types, 99.2% uptime, 97.7% completion rate, and patients from 20+ countries and regions.
Read More →